Jabil Research Note: Earnings Week Tests Infrastructure Growth and Cash Conversion
Jabil enters September 30 with infrastructure growth, stronger cash conversion, and a working-capital test that can shape its fiscal 2027 outlook.
CAMS Research Desk
CLDX: Replicated Phase 3 efficacy, unfinished commercial proof
CAMS Premium research on Celldex Therapeutics.
Micron Technology Research Note: Operating Momentum Faces a Durability Test
Micron Technology brings exceptional revenue, margin, and cash momentum to September 30, where HBM4 durability and cycle risk meet a high evidence bar.
CAMS Morning Market Brief: September 23, 2026
Both official Nasdaq calendars support a regular United States trading session today.
JBL: Earnings week tests an AI-driven rerating
CAMS Premium research on Jabil.
Conagra Brands Research Note: Demand and Cash Reset Face a September 30 Test
Conagra Brands enters September 30 with weaker demand, improving cash discipline, and a test of whether its fiscal reset can hold the stated frame.
CAG: A low multiple meets a demanding stabilization test
CAMS Premium research on Conagra Brands.
MU: Earnings durability meets cycle risk after an exceptional rerating
CAMS Premium research on Micron Technology.
CAMS Closing Market Recap: September 22, 2026
Oil was the biggest cross-asset move as growth stocks held the lead.
Desk Note: Oil Relief Strengthens the Breadth Test (Sep 22)
Positive breadth, a sub-5% 10-year yield, and Brent at a two-week low now align with the published market-structure confirmation test, although the oil relief remains conditional.